Why patient and public involvement and engagement is important and what it means to those involved
Have you ever thought about getting involved in research as a patient or supporter? In this episode, Ellie Wolmark talks to the incredible members of the Women⁺s Cancers Programme Patient and Public ...
12 Marras 20251h 16min
The association between radioresistance and tumour evolution
Is a tumour's ability to evolve and adapt over time linked to why it becomes resistant to radiotherapy? And if so, what can we do to overcome this radioresistance? In this episode, Dr Christopher Jon...
22 Loka 202545min
Using AI to mathematically model the progression of glioblastoma
Can we use artificial intelligence (AI) to predict where a brain tumour might recur at the point of first diagnosis in order to pre-emptively treat it to stop recurrence? Dr Francesca Cozzi (a PhD s...
8 Loka 202528min
Studying the tumour microenvironment
Could the environment around a cancer tumour hold the key to better treatments? In this episode, PhD students Emily Lythgoe and Ellie Bunce from the University of Cambridge discuss their research int...
24 Syys 202532min
Building a tissue time machine
What if a time machine could be built, not from metal but from human tissue, to help us understand cancer and how it responds to treatment? Dr Alecia-Jane Twigger, Dr Akanksha Anand, Dr Kui Hua, Dr P...
10 Syys 202545min
Using AI in the screening and treatment of kidney cancer
Have you ever wondered how artificial intelligence (AI) is used in research in a healthcare setting? Rebecca Wray and Bill McGough, two PhD students at the University of Cambridge, both use AI in diff...
27 Elo 202533min
Ask me anything about... cachexia research and management
What do you most want to know about pancreatic cancer and cancer-associated cachexia? In this special episode, we bring you a recording of a live 'Ask Me Anything (AMA)' event hosted by the CRUK Camb...
30 Heinä 202544min
